Navigation Links
Fuisz Pharma LLC Announces Acquisition of Dysmenorrhea Treatment
Date:4/18/2011

MIAMI, April 18, 2011 /PRNewswire/ -- Fuisz Pharma announced that it has secured an exclusive license for a vaginal treatment of dysmenorrhea. The exclusive license covers existing clinical work whereby a medicated tampon was used to deliver keterolac and it includes two issued United States patents.

Joseph Fuisz, Managing Partner of Fuisz Pharma, stated, "We are pleased to announce this acquisition, having had a long standing interest in vaginal drug delivery, and in particular in the exciting patent portfolio originated by UMD prior to its acquisition by Femina Pharma."

"We look forward to seeking a marketing partner for this treatment.  The existing oral methods are not satisfactory and we believe that the market is finally taking notice of consumer acceptance of vaginal delivery."

The Fuiszes currently have a personal, majority position in Femina Pharma.  Prior to Femina's acquisition of UMD's assets, they had concluded an earlier license of UMD's technology.

Joseph Fuisz continued: "We see an exciting future for Femina's vaginal drug delivery portfolio, through the licensed technology as well as through recent allowances in the anti viral area in which vaginal delivery has interesting applications.  Vaginal delivery of anti virals is particularly exciting in view of limited absorption of many of these compounds when administered orally."

About Fuisz Pharma:

Fuisz Pharma (www.fuisz.com) is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, and have extensive experience working with big and specialty pharma.


'/>"/>
SOURCE Fuisz Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
2. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
3. FUISZ Announces Advances in Devices and Solid Dosage Form
4. Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform
5. Fuisz Announces Issuance of Patent for the New Generation of Glucose and Other Analyte Analyzers
6. Fuisz Pharma Releases Clinical Photos of Its Opioid Abuse Detection System
7. Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
8. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... 1, 2015 /CNW Telbec/ -   Ergoresearch Ltd (TSXV: ... and known under the « Équilibre, orthèses et ... quarter Ended on December 31, 2014. All dollar amounts ... Revenues for the second quarter of fiscal ... $ 4 095 112 decreasing by 8,8 % compared to revenues of ...
(Date:3/1/2015)... , March 1, 2015  An innovative ... chronic migraine sufferers sustained relief of their headaches, ... Society of Interventional Radiology ,s Annual Scientific ... the State University New York Empire State College ... intranasal sphenopalatine ganglion (SPG) blocks to give patients ...
(Date:3/1/2015)... March 1, 2015  Patients suffering from chronic ... this debilitating foot ailment, according to research presented ... Annual Scientific Meeting . Researchers utilized ultrasound ... and remove diseased fasciitis tissue. Permanently removing damaged, ... regrow in its place, restoring normal function. ...
Breaking Medicine Technology:Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... 2007 (PrimeNewswire via COMTEX News,Network) -- Generex ... for metabolic diseases through the inner,lining of ... be making three,poster presentations at the 46th ... Endocrinology in Helsinki, Finland June 27 --,30, ...
... 10, 2007 - BusinessWeek,published an article on ... biotechnology companies to be first to bring ... While angiogenesis therapies are being pursued by,Sanofi-Aventis, ... article highlights a very promising new biological,therapy ...
Cached Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2
(Date:3/1/2015)... Women’s Excellence is pleased to announce the addition ... website. There are over 75 terms and phrases available for ... “This gives our patients a better understanding of what our Providers ... not understand. With this resource, our patients are able to ... terms and phrases that they may not remember or comprehend at ...
(Date:3/1/2015)... March 01, 2015 Women’s Excellence ... Overactive Bladder (OAB) symptoms, such as a strong need to ... type of medication (anticholinergic) does not work well enough or ... that takes another approach to targeting the source of OAB, ... the nerves and bladder muscle, blocking the signals that trigger ...
(Date:3/1/2015)... CA (PRWEB) March 01, 2015 Comparing ... be possible when using the Quotes Pros portal this ... including United auto insurance rates that are being supplied ... to the updated agencies and prices available for each ... zip code online. Every system user will first be ...
(Date:3/1/2015)... Adults who are not legally married in ... universal policies can now use the QuotesPros.com portal online. ... companies for single adults can now be researched for ... , The rate plans that nationwide agencies are now ... number of life protection policies. The term, universal and ...
(Date:3/1/2015)... Researchers say working around asbestos-containing construction products ... workers contract malignant mesothelioma. Surviving Mesothelioma has just posted ... Click here to read it now. , ... monitored 17,345 sheet metal workers from 1986 to 2010 ... of mesothelioma or another asbestos-related disease . , ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2
... testing in laboratory animals of a potential new material ... skin cancer. Their study is scheduled for the September ... Medicinal Chemistry , a bi-weekly publication. Ivan Greguric ... Biomedical Imaging Develop, an Australian Government funded research group, ...
... against the clock to deliver millions of doses of vaccine ... in the 2009-2010 flu season. A two-part cover story in ... ACS, weekly newsmagazine, focuses on that topic and efforts to ... Ann Thayer cites World Health Organization (WHO) estimates that one-third ...
... first-of its-kind study, epidemiologists at the University of Pennsylvania School of ... possessed them from being shot in an assault. The study ... to be shot in an assault than those not possessing a ... the American Journal of Public Health , in advance of ...
... electronic medical records holds the key, study finds , ... possible to use a person,s electronic medical records ... it actually occurs, according to U.S. researchers. , ... adults that included at least four years of data ...
... ... Matching Service Adds New "Trial Alert" and "SecureCONNECT" Web 2.0 Components, , ... San Francisco, ... dedicated exclusively to breast cancer--BreastCancerTrials.org--is now upgraded with new features, greatly expanding access ...
... ... steps to help organizations take a top-down approach to reduce audit burden and harmonize ... ... an organization spends 30-50 percent more on compliance and IT risk policy management than ...
Cached Medicine News:Health News:Penn study asks, protection or peril? Gun possession of questionable value in an assault 2Health News:Doctors May Be Able to Predict Domestic Abuse 2Health News:UCSF Announces Expanded BreastCancerTrials.org Website 2Health News:UCSF Announces Expanded BreastCancerTrials.org Website 3Health News:UCSF Announces Expanded BreastCancerTrials.org Website 4Health News:UCSF Announces Expanded BreastCancerTrials.org Website 5Health News:UCSF Announces Expanded BreastCancerTrials.org Website 6Health News:Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 2Health News:Lumension Sponsored Webinar Outlines Five Methods to Help Organizations Reduce IT Audit Tax Burdens 3
Contour design eyelid implants....
... aplanatic lens is made of ... system consisting of two plano-convex ... defined, distortion-free image. This lens ... patients with macular degeneration because ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
Medicine Products: